226.29 - 230.79
161.38 - 242.52
38.50M / 42.21M (Avg.)
34.73 | 6.57
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
241.62%
Net income growth above 1.5x JD's 36.17%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
6.36%
D&A growth well above JD's 8.99%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
57.80%
Deferred tax of 57.80% while JD is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
6.66%
Less SBC growth vs. JD's 25.81%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
34.98%
Working capital change of 34.98% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
29.49%
AR growth of 29.49% while JD is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
118.82%
Inventory growth of 118.82% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
-133.14%
Negative yoy AP while JD is 0.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
103.12%
Growth of 103.12% while JD is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
-118.45%
Both negative yoy, with JD at -102.55%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
27.21%
Some CFO growth while JD is negative at -72.82%. John Neff would note a short-term liquidity lead over the competitor.
-4.16%
Negative yoy CapEx while JD is 2.82%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-241.70%
Negative yoy acquisition while JD stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
27.36%
Purchases growth of 27.36% while JD is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-78.64%
We reduce yoy sales while JD is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-17.77%
We reduce yoy other investing while JD is 82.53%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-29.23%
We reduce yoy invests while JD stands at 68.46%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
86.87%
Debt repayment growth of 86.87% while JD is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Buyback growth of 100.00% while JD is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.